PURPOSE OF REVIEW: Estimated glomerular filtration rate (eGFR) is now commonly reported by clinical laboratories. Here, we review the performance of current creatinine and cystatin C-based estimating equations as well as demonstration of their utility in public health and clinical practice. RECENT FINDINGS: Lower levels of GFR are associated with multiple adverse outcomes, including acute kidney injury and medical errors. The new Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation improves performance and risk prediction compared with the Modification of Diet in Renal Disease study equation. Current cystatin C-based equations are not accurate in all populations, even in those with reduced muscle mass or chronic illness, in which cystatin C would be expected to outperform creatinine. eGFR reporting has led to a greater number of referrals to nephrologists, but the increased numbers do not appear to be excessive or burdensome. The Modification of Diet in Renal Disease study equation appears to be able to provide drug dosage adjustments similar to the Cockcroft-Gault equation. SUMMARY: Estimated GFRs and their reporting can improve and facilitate clinical practice for chronic kidney disease. Understanding strengths and limitations facilitates their optimal use. Endogenous filtration markers, alone or in combination, which are less dependent on non-GFR determinants of the filtration markers, are necessary to lead to more accurate eGFRs.
PURPOSE OF REVIEW: Estimated glomerular filtration rate (eGFR) is now commonly reported by clinical laboratories. Here, we review the performance of current creatinine and cystatin C-based estimating equations as well as demonstration of their utility in public health and clinical practice. RECENT FINDINGS: Lower levels of GFR are associated with multiple adverse outcomes, including acute kidney injury and medical errors. The new Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation improves performance and risk prediction compared with the Modification of Diet in Renal Disease study equation. Current cystatin C-based equations are not accurate in all populations, even in those with reduced muscle mass or chronic illness, in which cystatin C would be expected to outperform creatinine. eGFR reporting has led to a greater number of referrals to nephrologists, but the increased numbers do not appear to be excessive or burdensome. The Modification of Diet in Renal Disease study equation appears to be able to provide drug dosage adjustments similar to the Cockcroft-Gault equation. SUMMARY: Estimated GFRs and their reporting can improve and facilitate clinical practice for chronic kidney disease. Understanding strengths and limitations facilitates their optimal use. Endogenous filtration markers, alone or in combination, which are less dependent on non-GFR determinants of the filtration markers, are necessary to lead to more accurate eGFRs.
Authors: Mário L de Lemos; Teresa Hsieh; Linda Hamata; Adeera Levin; Ken Swenerton; Ognjenka Djurdjev; Thanh Vu; Francis Hu; James Conklin; Suzanne C Malfair Taylor Journal: Gynecol Oncol Date: 2006-07-27 Impact factor: 5.482
Authors: Kurt A Wargo; Edward H Eiland; Wayne Hamm; Thomas M English; Haley M Phillippe Journal: Ann Pharmacother Date: 2006-07-11 Impact factor: 3.154
Authors: Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak Journal: J Am Coll Cardiol Date: 2003-01-01 Impact factor: 24.094
Authors: Rossini Botev; Jean-Pierre Mallié; Cecilé Couchoud; Otto Schück; Jean-Pierre Fauvel; Jack F M Wetzels; Nelson Lee; Natale G De Santo; Massimo Cirillo Journal: Clin J Am Soc Nephrol Date: 2009-04-30 Impact factor: 8.237
Authors: Alison G Abraham; George J Schwartz; Susan Furth; Bradley A Warady; Alvaro Muñoz Journal: Clin J Am Soc Nephrol Date: 2009-09-17 Impact factor: 8.237
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Smita Padala; Hocine Tighiouart; Lesley A Inker; Gabriel Contreras; Gerald J Beck; Julia Lewis; Michael Steffes; Roger A Rodby; Christopher H Schmid; Andrew S Levey Journal: Am J Kidney Dis Date: 2012-04-10 Impact factor: 8.860
Authors: Adrienne Tin; Brad C Astor; Eric Boerwinkle; Ron C Hoogeveen; Josef Coresh; W H Linda Kao Journal: Nephrol Dial Transplant Date: 2013-01-16 Impact factor: 5.992
Authors: Aghogho A Okparavero; Hocine Tighiouart; Zipporah Krishnasami; Christina M Wyatt; Hiba Graham; James Hellinger; Lesley A Inker Journal: Antivir Ther Date: 2013-08-20
Authors: Almudena Vega; Soledad García de Vinuesa; Marian Goicoechea; Ursula Verdalles; María Luz Martínez-Pueyo; Ana Chacón; Borja Quiroga; José Luño Journal: Int Urol Nephrol Date: 2013-11-22 Impact factor: 2.370